A cutting-edge liquid biopsy product that analyzes circulating tumor DNA (ctDNA) to identify somatic mutations. It aids in treatment selection, response monitoring, and recurrence detection for optimal cancer care.
Manufactured by
Dxome Co., Ltd.
Seongnam-si, Gyeonggi-do, South Korea
Dxome Co., Ltd. is a molecular diagnostics company specializing in next-generation sequencing (NGS)–based solutions with a strong focus on liquid biopsy. By analyzing circulating tumor DNA (ctDNA) and hereditary mutations from a simple blood sample, Dxome enables early cancer detection, treatment selection, therapy monitoring, and recurrence detection with exceptional sensitivity and accuracy. Its integrated approach—combining proprietary reagents, advanced sequencing panels, bioinformatics pipelines, and clinical reporting—has led to innovative products such as DxLiquid Pan100 and DxLiquid TMB500 , which reduce the need for invasive tissue biopsies and support personalized medicine. Guided by its mission to deliver precise insights that improve patient outcomes, Dxome continues to invest in R D, pursue global certifications including CLIA accreditation, and collaborate with hospitals and research institutions worldwide, positioning itself as a trusted leader in precision diagnostics for cancer and genetic diseases.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Biopsense Oy
Finland · 4 relevant products
GENETRON HEALTH (BEIJING) CO., LTD
China · 3 relevant products
NOROVA
China · 4 relevant products
44 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 84 closest product alternatives
Biopsense Oy · Finland
Liquid biopsy diagnostic solution for non-invasive cancer monitoring and treatment personalization through cell-free DNA analysis. Automates plasma separation, DNA extraction, and quantitation to reduce pre-analytical variability and enable frequent patient monitoring for improved treatment response assessment.
GENETRON HEALTH (BEIJING) CO., LTD · China
Molecular diagnostic test utilizing circulating tumor DNA and biomarkers from blood samples. Enables non-invasive cancer screening and early detection. Supports monitoring of treatment response and recurrence in cancer patients.
NOROVA · China
Precision diagnostic service utilizing liquid biopsy technology for early detection and monitoring of malignant tumors. Analyzes circulating biomarkers from patient blood samples. Enables non-invasive assessment of tumor characteristics and treatment response.
81 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products